Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine in Intensive Care Patients
NCT00922714Phase 4Terminated
- Sponsor
- Scandinavian Critical Care Trials Group
- Start
- Oct 2003
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glutamine in critical illness, sponsored by Scandinavian Critical Care Trials Group. Started Oct 2003; status: terminated.
02
Drugs
glutamine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT00922714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922714.